"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Consultants from Mazars helped green light three scandal-plagued deals. Now – after all three imploded – internal documents ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The company’s shares closed yesterday at $63.22.

CVS today announced the launch of a newly rebranded and updated CVS Health app (formerly called CVS Pharmacy). The iPhone app offers a variety of new features, but perhaps the most exciting is one ...

CVS Health (CVS) is up 14.0%, or $7.71 to $62.71. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing ...

(Reuters) - CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that ...

If you've ever been frustrated while shopping at your local pharmacy, you're hardly alone — but now CVS has devised a plan to change that with it's new iPhone app. Pharmacies often get ...

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." The S&P 500 hit a new all-time high on Feb. 18. We highlight five stocks in ...

CVS closed nine stores in Connecticut in 2024, but they say there are no other closures planned for 2025 at this time - other than these two. They're not the only big brand store to close ...